Definition and diagnosis of dementia with Lewy bodies

Dementia and Geriatric Cognitive Disorders

Volumn 17, Issue SUPPL. 1, 2004, Pages 15-24

  Ballard, Clive G ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Clinical evaluation methods; Consensus criteria; Dementia with Lewy bodies; Diagnosis; Neuropathology; Neuropsychology; Parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; FAMOTIDINE; FLUORINE 18; FLUORODEOXYGLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPRAMINE; LEVODOPA; NEUROLEPTIC AGENT; OXYBUTYNIN; PROPANTHELINE BROMIDE; RANITIDINE; SELEGILINE; SPASMOLYTIC AGENT;

AGED; ALERTNESS; ALZHEIMER DISEASE; ANOSMIA; ATTENTION DEFICIT DISORDER; AUDITORY HALLUCINATION; AUTOPSY; BRADYKINESIA; CHOLINERGIC NERVE CELL; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONFUSION; CONSCIOUSNESS DISORDER; DELUSION; DEMENTIA; DEPRESSION; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DROWSINESS; DRUG SENSITIVITY; EXTRAPYRAMIDAL SYMPTOM; FALLING; HALLUCINATION; HUMAN; LABORATORY TEST; LEWY BODY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MULTIINFARCT DEMENTIA; MUSCLE RIGIDITY; NEUROFIBRILLARY TANGLE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; QUESTIONNAIRE; REM SLEEP; REVIEW; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SYNCOPE; VALIDATION PROCESS; VISUAL HALLUCINATION;

AGED; ALZHEIMER DISEASE; BRAIN; COMORBIDITY; CRITICAL PATHWAYS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LEWY BODY DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 0348010570     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074678     Document Type: Review

References (66)

1. Barber R, Panikkar A, McKeith IG: Dementia with Lewy bodies: Diagnosis and management. Int J Geriatr Psychiatry 2001;16(suppl 1):S12-S18.
2. McKeith IG: Dementia with Lewy bodies. Br J Psychiatry 2002;180:144-147.
3. Mark MH: Lumping and splitting the Parkinson Plus syndromes: Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration. Neurol Clin 2001;19:607-27, vi.
4. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
5. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E: Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
6. Ballard C, Grace J, McKeith I, Holmes C: Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998;351: 1032-1033.
7. Woodard JS: Concentric hyaline inclusion body formation in mental disease: analysis of twenty-seven cases. J Neuropathol Exp Neurol 1962;2:442-449.
8. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT: Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 1999;53:1284-1291.
9. Gomez-Isla T, Growdon WB, McNamara M, Newell K, Gomez-Tortosa E, Hedley-Whyte ET, Hyman BT: Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 1999;53:2003-2009.
10. Feany MB, Bender WW: A Drosophilamodel of Parkinson's disease. Nature 2000;404:394-398.
11. Hamilton RL: Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000;10:378-384.
12. Lopez OL, Becker JT, Kaufer DI, Hamilton RL, Sweet RA, Klunk W, DeKosky ST: Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol 2002;59:43-46.
13. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M: The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8.
14. Del Ser T, Hachinski V, Merskey H, Munoz DG: Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: Effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 2001;15:31-44.
15. Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E: Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 2000;48:868-876.
16. Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT: α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol (Berl) 2000;99:352-357.
17. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M: Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999;45: 601-610.
18. Kuikka JT, Bergstrom KA, Vanninen E, Laulumaa V, Hartikainen P, Lansimies E: Initial experience with single-photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3-β-(4-iodophenyl) tropane in human brain. Eur J Nucl Med 1993;20:783-786.
19. Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA: In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996;40:399-410.
20. Lange KW, Wells FR, Jenner P, Marsden CD: Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J Neurochem 1993;60: 197-203.
21. Piggott MA, Marshall EF: Neurochemical correlations of pathological and iatrogenic extrapyramidal symptoms; in Perry RH, McKeith IG, Perry EK (eds): Dementia with Lewy Bodies: Clinical, Pathological and Treatment Issues. Cambridge, MA, Cambridge University Press, 1996, pp 449-467.
22. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW: Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102-112.
23. Aarsland D, Tandberg E, Larsen JP, Cummings JL: Frequency of dementia in Parkinson disease. Arch Neurol 1996;53:538-542.
24. Aarsland D, Ballard C, Larsen JP, McKeith I: A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001;16:528-536.
25. Okamoto K, Tanaka M, Kondo S: Treatment of vascular dementia. Ann NY Acad Sci 2002;977:507-512.
26. Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP: Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:374-379.
27. Goedert M: Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001;2:492-501.
28. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG: The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000;177:252-256.
29. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK: Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050-1058.
30. Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R: Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999;156:1039-1045.
31. Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R: The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:97-103.
32. Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E: Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 1999;10:1903-1907.
33. Aarsland D, Bronnick K, Karlsen K: Donepezil for dementia with Lewy bodies: A case study. Int J Geriatr Psychiatry 1999;14:69-72.
34. Sadek J, Rockwood K: Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy body dementia. Am J Geriatr Psychiatry 2003;11:112-113.
35. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL: Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
36. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y: Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998;55:969-978.
37. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST: Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999;53:1292-1299.
38. Luis CA, Barker WW, Gajaraj K, Harwood D, Petersen R, Kashuba A, Waters C, Jimison P, Pearl G, Petito C, Dickson D, Duara R: Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 1999;14:526-533.
39. Holmes C, Cairns N, Lantos P, Mann A: Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999;174:45-50.
40. Lopez OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, DeKosky ST: Predictors of progression in patients with AD and Lewy bodies. Neurology 2000;54:1774-1779.
41. Lopez OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST: Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 2000;54:1780-1787.
42. Ancoli-Israel S, Walsh JK, Mangano RM, Fujimori M: Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Primary Care Companion J Clin Psychiatry 1999;1:114-120.
43. Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J: Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 2000;57:347-351.
44. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG: Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000;54:1616-1625.
45. Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG: Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:327-335.
46. Ballard C, O'Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, Tovee M: Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol 2001;58:977-982.
47. Doubleday EK, Snowden JS, Varma AR, Neary D: Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:602-607.
48. Grace JB, Walker MP, McKeith IG: A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:1028-1033.
49. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE: Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-630.
50. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD: Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001;70:739-743.
51. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK: Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
52. Klatka LA, Louis ED, Schiffer RB: Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996;47:1148-1152.
53. Hirono N, Cummings JL: Neuropsychiatric aspects of dementia with Lewy bodies. Curr Psychiatry Rep 1999;1:85-92.
54. Calderon J, Perry RJ, Erzinclioglu SW, Berrios GE, Dening TR, Hodges JR: Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;70:157-164.
55. Walker Z, Allen RL, Shergill S, Katona CL: Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry 1997;170:156-158.
56. Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH: Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1999;10:104-108.
57. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P: Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997;62:243-252.
58. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M: The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8.
59. O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC: Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001;56:1386-1388.
60. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E: Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology 1998;51:357-362.
61. Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT: A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001;12:198-205.
62. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Hashimoto M, Hirono N, Shimomura T, Mori E: Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-130.
63. Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T, Sasaki M, Mori E: Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: A study using positron emission tomography. Dement Geriatr Cogn Disord 2001;12:194-197.
64. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
65. Ballard C, Thomas A: Neuropsychiatric co-morbidity in dementia with and without movement disorders; in Bedard MA (ed): Psychiatric Aspects of Parkinson's Disease. Humana Press, 2003.
66. Aarsland D, Ballard C: Psychiatric issues in non-AD dementias. J Clin Neurosci 2003, in press.